This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Dissertation titles

  Dissertation Title Supervisor
List of dissertation titles
1 Molecular mechanisms underlying opioid tolerance. Professor Graeme Henderson, University of Bristol
2 Gene-deletion of prostanoid receptors will improve our knowledge of disease processes and lead to clinically useful drugs. Professor Robert Jones, University of Strathclyde
3 Do endogenous biolipids have a role in regenerative medicine? Professor Anwar R Baydoun, University of Hertfordshire
4 How could biomarkers be exploited in understanding and/or managing vascular calcification?Professor Anwar R Baydoun, University of Hertfordshire
5 Cationic amino acid transporters as novel targets for therapeutic intervention in cardiovascular diseases.
6 Evaluation of the evidence that MDMA ('ecstasy') produces neurotoxic damage in the human brain. Professor A. Richard Green, University of Nottingham
7 Molecular determinants of ion channel conduction in Cys-loop receptors. Professor John Peters, University of Dundee
8 Safe limits for driving when taking medication. Dr Paul Skett, University of Glasgow
9 Heroin - a dangerous drug?
10 Understanding ligand bias and its potential for pharmacological and therapeutic advantage. Professor R.A. John Challiss, University of Leicester
11 Nitric oxide-independent/heme-independent soluble guanylyl cyclase activators: molecular mechanism of action and therapeutic potential. Professor Andreas Papapetropoulos, University of Patras, Greece
12 Therapeutic opportunities for gasotransmitters and gasotransmitter-inhibitor drugs.
13 Agents (approved from human use or in development) that target vascular endothelial growth factor: mechanisms of action and therapeutic applications.
14 Lifestyle drugs and their impact on society. Professor Rod Flower, The William Harvey Research Institute, Queen Mary, University of London
15 Formyl peptide receptor biology. Professor Mauro Perretti, The William Harvey Research Institute, Queen Mary, University of London
16 Anti-thrombotics that target the platelet; what old and new drugs might we be using in ten years' time? Professor Tim Warner, The William Harvey Research Institute, Queen Mary, University of London
17 Novel corticosteroid therapeutics - what does the future hold? Professor Nick Goulding, The William Harvey Research Institute, Queen Mary, University of London
18 Discuss the therapeutic potential of inorganic nitrite/nitrate based therapy. Professor Amrita Ahluwalia, The William Harvey Research Institute, Queen Mary, University of London
19 Therapeutic potential of female sex hormones in treatment of cardiovascular diseases. Dr Ramona Scotland, The William Harvey Research Institute, Queen Mary, University of London
20 Describe how amino acids and their analogues/ derivatives are used as drugs: include a description of potential novel therapeutic uses and short peptide sequences where the activity relates mainly to a single amino acid. Dr Andy Webb, King’s College London
21 Is inflammation good or bad? Dr Derek Gilroy, University College London
22 Despite the rigours of drug development, why do some drugs still fail at the ultimate step (the RCT)? Dr Aroon Hingorani, University College London
23 Discuss the therapeutic potential of NOS inhibitors. Professor Adrian Hobbs, Barts and The London School of Medicine and Dentistry at Queen Mary, University of London
24 Aspirin - the new wonder drug: As an analgesic aspirin is associated with significant side effects; however in recent years several new indications for aspirin have started to emerge - critically review the evidence for these alternative uses of aspirin. Dr Fiona Dowell, University of Glasgow Veterinary School
25 The future of pharmacological treatments in veterinary medicine is pharmacogenetics - discuss.
26 Can fluorescent receptor ligands and transporter substrates be used to efficiently and safely screen for new drugs?
Dr Keith Brain, University of Birmingham
27 Targeting the vicious cycle of cancer-induced bone disease. Dr Claire M. Edwards, University of Oxford
28 An insight into the relationship between inflammation and cancer and COX-2 as a potential target in colon cancer therapy. Dr Naeem Mubarak, Hamdard University, Pakistan
29 Current and novel therapies for acute kidney injury. Jill Darton, GlaxoSmithKline, UK